Significance of hemoglobin and hematocrit changes in predicting patient survival and efficacy of neoadjuvant chemotherapy for advanced gastric cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

121

Figures (1-1)

Tables (1-4)

Sum=222

Publishing Process of This Article

Item

Count

Browse

Download

Sum=88

Jun 15, 2025 (publication date) through Jun 19, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Jun 15, 2025; 17(6): 104592
Published online Jun 15, 2025. doi: 10.4251/wjgo.v17.i6.104592

Table 3 Comparison of 3-year survival in patients with advanced gastric cancer treated with neoadjuvant chemotherapy, n (%)

Citation: Qiu TH, Wen HY, Huang YL. Significance of hemoglobin and hematocrit changes in predicting patient survival and efficacy of neoadjuvant chemotherapy for advanced gastric cancer. World J Gastrointest Oncol 2025; 17(6): 104592
URL: https://www.wjgnet.com/1948-5204/full/v17/i6/104592.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i6.104592